ArticleDrug design, development and therapy2026
Zero Events, Limited Precision, and the Interpretation of Olanzapine Safety in Patients with Diabetes Receiving Cisplatin [Response to Letter].
Toshinobu Hayashi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.